Table 3.
Logistic Models of the Association Between ALPS Index and Trajectories in iRBD
Model term | Conversion to PDa | Conversion to DLBa | ||||
Coefficient (SE) | p Value | OR (95% CI) | Coefficient (SE) | p Value | OR (95% CI) | |
Model 1: DTI-ALPS | ||||||
DTI-ALPS index, left | −0.424 (0.20) | 0.029 | 0.654 (0.447–0.958) | 0.03 (0.26) | 0.901 | 1.03 (0.62–1.71) |
Age | −0.003 (0.03) | 0.92 | 1.00 (0.95–1.05) | 0.03 (0.04) | 0.42 | 1.03 (0.96–1.11) |
Sex | −0.27 (0.67) | 0.68 | 0.76 (0.21–2.80) | 0.37 (0.70) | 0.59 | 1.45 (0.37–5.70) |
Constant | −1.19 (1.77) | 0.50 | 0.30 | −4.22 (2.51) | 0.09 | 0.02 |
Model 2: MoCA score | ||||||
DTI-ALPS index, left | −0.389 (0.19) | 0.045 | 0.678 (0.46–0.99) | −0.004 (0.28) | 0.999 | 1.00 (0.58–1.72) |
Age | 0.003 (0.03) | 0.92 | 1.00 (0.95–1.06) | 0.01 (0.04) | 0.80 | 1.01 (0.93–1.09) |
Sex | −0.13 (0.68) | 0.84 | 0.88 (0.23–3.30) | 0.45 (0.77) | 0.56 | 1.56 (0.35–7.03) |
MoCA score | −0.003 (0.07) | 0.968 | 1.00 (0.88–1.14) | −0.28 (0.09) | 0.001 | 0.75 (0.64–0.89) |
Constant | −1.45 (2.71) | 0.59 | 0.24 | 4.10 (3.62) | 0.26 | 60.26 |
Model 3: MDS-UPDRS-III score | ||||||
DTI-ALPS index, left | −0.41 (0.20) | 0.035 | 0.66 (0.45–0.97) | −0.03 (0.27) | 0.911 | 0.97 (0.58–1.63) |
Age | −0.01 (0.03) | 0.67 | 0.98 (0.94–1.04) | 0.024 (0.04) | 0.56 | 1.02 (0.95–1.11) |
Sex | −0.19 (0.68) | 0.78 | 0.83 (0.22–3.13) | 0.48 (0.73) | 0.51 | 1.61 (0.39–6.71) |
MDS-UPDRS-III score | 0.01 (0.03) | 0.73 | 1.01 (0.95–1.08) | 0.05 (0.04) | 0.19 | 1.05 (0.98–1.14) |
Constant | −0.58 (1.82) | 0.75 | 0.56 | −4.16 (2.70) | 0.12 | 0.02 |
Abbreviations: DLB = dementia with Lewy bodies; DTI-ALPS = diffusion tensor imaging along the perivascular space; iRBD = isolated REM sleep behavior disorder; MDS = Movement Disorder Society; MoCA = Montreal Cognitive Assessment; OR = odds ratio; PD = Parkinson disease; SE = standard error; UPDRS-III = motor scale of the Unified Parkinson's Disease Rating Scale.
Values in bold represent significant predictors.
Tested against staying disease-free in the longitudinally followed iRBD cohort.